Stoke Therapeutics, Inc. STOK Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s interest expense?
- Stoke Therapeutics, Inc. (STOK) reported interest expense of $3.4M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s interest expense changed year-over-year?
- Stoke Therapeutics, Inc.'s interest expense increased by 17.6% year-over-year, from $2.89M to $3.4M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s interest expense?
- Over 4 years (2021 to 2025), Stoke Therapeutics, Inc.'s interest expense has grown at a 227.2% compound annual growth rate (CAGR), from $120K to $13.76M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.